Glandular lesions of the uterine cervix

Modern Pathology

Volumn 13, Issue 3, 2000, Pages 261-274

  Zaino, Richard J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Adenocarcinoma in situ; Cervix; Cervix neoplasm; Cervix nonneoplastic

Indexed keywords

ADENOCARCINOMA; ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CLEAR CELL CARCINOMA; DYSPLASIA; ENDOMETRIOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; INVASIVE CARCINOMA; MESONEPHROMA; METAPLASIA; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX HYPERTROPHY;

EID: 0034127549     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880047     Document Type: Article

References (73)

1. Kurman R, Norris H, Wilkinson E. Tumors of the cervix, vagina, and vulva. Vol. 4. Washington, DC: Armed Forces Institute of Pathology; 1992.
2. Friedell G, McKay D. Adenocarcinoma in situ of the endocervix. Cancer 1953;6:887-97.
3. Christopherson W, Nealon N, Gray L. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 1979;44:975-83.
4. Qizilbash A. In-situ and microinvasive adenocarcinoma of the uterine cervix. Am J Clin Pathol 1975;64:155-70.
5. Liao SY, Brewer C, Zavada J, Pastorek J, Pastorekova S, Manetta A, et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 1994;145(3):598-609.
6. Jaworski R. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn Pathol 1990;7: 190-205.
7. Casper G, Ostor A, Quinn M. A clinicopathologic study of glandular dysplasia of the cervix. Gynecol Oncol 1997;64: 166-70.
8. Gompel C, Silverberg S. Pathology in gynecology and obstetrics. Philadelphia: Lippincott; 1994.
9. Brown LJ, Wells M. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol 1986;39(1):22-8.
10. Gloor E, Hurlimann J. Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ and glandular dysplasia): a correlative study of 23 cases with histologic grading, histochemical analysis of mucins, and immunohistochemical determination of the affinity for four lectins. Cancer 1986;58(6): 1272-80.
11. Clement P, Young R. Deep Nabothian cysts of the uterine cervix. Int J Gynecol Pathol 1989;8:340-8.
12. Fluhmann C. Focal hyperplasia (tunnel clusters) of the cervix uteri. Obstet Gynecol 1961;17:206-14.
13. Clement P, Young R. Tumors and tumorlike lesions of the uterine corpus and cervix. In: Roth L, editor. Contemporary issues in surgical pathology. Vol. 19. New York: Churchill Livingstone; 1993. p. 486.
14. Yeh IT, Li Volsi VA, Noumoff JS. Endocervical carcinoma. Pathol Res Pract 1991;187(2-3):129-44.
15. Noda K, Kimura K, Ikeda M, Teshima K. Studies on the histogenesis of cervical adenocarcinoma. Int J Gynecol Pathol 1983;1:336-46.
16. Fu Y, Reagan J. Pathology of the uterine cervix, vagina, and vulva. Vol. 21. Philadelphia: W.B. Saunders; 1989.
17. Burghardt E. Microinvasive carcinoma in gynaecological pathology. Clin Gynaecol Obstet 1984;11:239-44.
18. Buscema J, Woodruff J. Significance of neoplastic abnormalities in endocervical epithelium. Gynecol Oncol 1984;17:356-62.
19. Ostor A, Rome R, Quinn M. Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women. Obstet Gynecol 1997;89(1):88-93.
20. Berek J, Hacker N, Fu Y, Sokale J, Leuchter R, Lagasse L. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 1985;65:46-52.
21. Teshima S, Shimosato Y, Kishi K, Kasamatsu T, Ohmi K, Uei Y. Early stage adenocarcinoma of the uterine cervix: histopathologic analysis with consideration of histogenesis. Cancer 1985;56(1):167-72.
22. Kaspar HG, Dinh TV, Doherty MG, Hannigan EV, Kumar D. Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix. Obstet Gynecol 1993:81(2): 296-300.
23. Vesterinen E, Forss M, Nieminen U. Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements. Gynecol Oncol 1989;33(1):49-53.
24. Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1986;76(3):423-8.
25. Schwartz S, Weiss N. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 1986;124:1045-7.
26. Brinton LA, Huggins GR, Lehman HF, Mallin K, Savitz DA, Trapido E, et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986;38(3):399-44.
27. Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA, et al. Epidemiology of cervical cancer by cell type. Cancer Res 1987;47(6):1706-11.
28. Okagaki T, Tase T, Twiggs LB, Carson LF. Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen. J Reprod Med 1989;34(9): 639-44.
29. Farnsworth A, Laverty C, Stoler MH. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 1989;8(4):321-30.
30. Tase T, Okagaki T, Clark BA, Twiggs LB, Ostrow RS, Faras AJ. Human papillomavirus DNA in glandular dysplasia and microglandular hyperplasia: presumed precursors of adenocarcinoma of the uterine cervix. Obstet Gynecol 1989;73(6): 1005-8.
31. Duggan MA, McGregor SE, Benoit JL, Inoue M, Nation JG, Stuart GC. The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis. Hum Pathol 1995;26(3):319-25.
32. Milde-Langosch K, Schreiber C, Becker G, Loning T, Stegner HE. Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction. Hum Pathol 1993; 24(6):590-4.
33. Yamakawa Y, Forslund O, Teshima H, Hasumi K, Kitagawa T, Hansson BG. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol 1994;53:190-5.
34. Chilvers C, Mant D, Pike M. Cervical adenocarcinoma and oral contraceptives. Br J Med (Clin Res Ed) 1987;295:1446-7.
35. Vessey M, Lawless M, McPherson K, Yeates D. Neoplasia of the cervix uteri and contraceptive use: a possible adverse effect of the pill. Lancet 1983;2:930-4.
36. Dallenbach-Hellweg G. On the origin and histologic structure of adenocarcinoma of the endocervix in women under 50 years of age. Pathol Res Pract 1984;179:38-50.
37. Ursin G, Peters RK, Henderson BE, d'Ablaing G III, Monroe KR, Pike MC. Oral contraceptive use and adenocarcinoma of cervix. Lancet 1994;344(8934):1390-4.
38. Thomas DB, Ray RM. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix: the World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol 1996;144(3):281-9.
39. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-6.
40. Look KY, Brunetto VL, Clarke-Pearson DL, Averette HE, Major FJ, Alvarez RD, et al. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1996;63: 304-11.
41. Dabbs DJ, Sturtz K, Zaino RJ. The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996;27(2):172-7.
42. Young RH, Scully RE. Villoglandular papillary adenocarcinoma of the uterine cervix: a clinicopathologic analysis of 13 cases. Cancer 1989;63(9):1773-9.
43. Jones MW, Silverberg SG, Kurman RJ. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases. Int J Gynecol Pathol 1993; 12(1):1-7.
44. Kaku T, Kamura T, Shigematsu T, Sakai K, Nakanami N, Uehira K, et al. Adenocarcinoma of the uterine cervix with predominantly villoglandular papillary growth pattern. Gynecol Oncol 1997;64(1):147-52.
45. Michael H, Sutton G, Hull MT, Roth LM. Villous adenoma of the uterine cervix associated with invasive adenocarcinoma: a histologic, ultrastructural, and immunohistochemical study. Int J Gynecol Pathol 1986;5(2):163-9.
46. Kaku T, Enjoji M. Extremely well-differentiated adenocarcinoma (adenoma malignum) of the cervix. Int J Gynecol Pathol 1983;2:28-41.
47. Kaminski P, Norris H. Minimal deviation carcinoma (adenoma malignum) of the cervix. Int J Gynecol Pathol 1983;2:141-52.
48. Gilks C, Young R, Aguirre P, DeLellis R, Scully R. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. Am J Surg Pathol 1989;13:717-29.
49. Michael H, Grawa L, Kraus F. Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for CEA, and differentiation from confusing benign lesions. Int J Gynecol Pathol 1984;3:261-76.
50. Young RH, Scully RE. Minimal-deviation endometrioid adenocarcinoma of the uterine cervix: a report of five cases of a distinctive neoplasm that may be misinterpreted as benign. Am J Surg Pathol 1993;17(7):660-5.
51. Gilks CB, Clement PB. Papillary serous adenocarcinoma of the uterine cervix: a report of three cases. Mod Pathol 1992; 5(4):426-31.
52. Zhou C, Gilks CB, Hayes M, Clement PB. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol 1998;22:113-20.
53. Ferry JA, Scully RE. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix: a study of 49 cases. Am J Surg Pathol 1990;14(12):1100-11.
54. Valente PT, Susin M. Cervical adenocarcinoma arising in florid mesonephric hyperplasia: report of a case with immunocytochemical studies. Gynecol Oncol 1987;27(1):58-68.
55. Lang G, Dallenbach-Hellweg G. The histogenetic origin of cervical mesonephric hyperplasia and mesonephric adenocarcinoma of the uterine cervix studied with immunohistochemical methods. Int J Gynecol Pathol 1990;9(2):145-57.
56. Ferry JA, Scully RE. "Adenoid cystic" carcinoma and adenoid basal carcinoma of the uterine cervix: a study of 28 cases. Am J Surg Pathol 1988;12(2):134-44.
57. Grayson W, Taylor L, Cooper K. Adenoid cystic and adenoid basal carcinoma of the uterine cervix. Am J Surg Pathol 1999;23:448-58.
58. Cina SJ, Richardson MS, Austin RM, Kurman RJ. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997;10(3):176-80.
59. Fluhmann C. The glandular structures of the cervix uteri. Surg Gynecol Obstet 1958;106:715-23.
60. Segal GH, Hart WR. Cystic endocervical tunnel clusters: a clinicopathologic study of 29 cases of so-called adenomatous hyperplasia. Am J Surg Pathol 1990;14(10):895-903.
61. Jones MA, Young RH, Scully RE. Diffuse laminar endocervical glandular hyperplasia: a benign lesion often confused with adenoma malignum (minimal deviation adenocarcinoma). Am J Surg Pathol 1991;15(12):1123-9.
62. Taylor H, Irey N, Norris H. Atypical endocervical hyperplasia in women taking oral contraceptives. JAMA 1967;202:185-90.
63. Kyriakos M, Kempson R, Konikov N. A clinical and pathologic study of endocervical lesions associated with oral contraceptives. Cancer 1968;22:99-109.
64. Greeley C, Schroeder S, Silverberg SG. Microglandular hyperplasia of the cervix: a true "pill" lesion? Int J Gynecol Pathol 1995;14(1):50-4.
65. Young RH, Scully RE. Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma: a report of five cases and review of the literature. Am J Surg Pathol 1989; 13(1):50-6.
66. Jones MA, Andrews J, Tarraza HM. Mesonephric remnant hyperplasia of the cervix: a clinicopathologic analysis of 14 cases. Gynecol Oncol 1993;49(1):41-7.
67. Jonasson JG, Wang HH, Antonioli DA, Ducatman BS. Tubal metaplasia of the uterine cervix: a prevalence study in patients with gynecologic pathologic findings. Int J Gynecol Pathol 1992;11(2):89-95.
68. Suh KS, Silverberg SG. Tubal metaplasia of the uterine cervix. Int J Gynecol Pathol 1990;9(2):122-8.
69. McCluggage WG, Maxwell P, McBride HA, Hamilton PW, Bharucha H. Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material. Int J Gynecol Pathol 1995;14(3):209-16.
70. Oliva E, Clement PB, Young RH. Tubal and tuboendometrioid metaplasia of the uterine cervix: unemphasized features that may cause problems in differential diagnosis: a report of 25 cases. Am J Clin Pathol 1995;103(5):618-23.
71. Schlesinger C, Silverberg SG. Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia. Int J Gynecol Pathol 1999;18:1-4.
72. Cove H. The Arias-Stella reaction occurring in the endocervix in pregnancy. Am J Surg Pathol 1979;3:567-8.
73. Goldstein NS, Mani A. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Am J Clin Pathol 1998; 109(6):727-32.